New Drug To Fight Against Localized High-Risk Prostate Tumors
Men with prostate cancer could significantly benefit from a recently approved hormone-depleting drug, according to results from a phase II clinical trial. The drug - abiraterone acetate (Zytiga(R)) - can help eliminate or almost eliminate tumors in many prostate cancer patients whose cancer has not yet metastasized. The study, conducted by researchers at Dana-Farber Cancer Institute in collaboration with other research centers, will be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), June 1-5, in Chicago... (Source: Health News from Medical News Today)

Person with active tuberculosis visited two Calif. neonatal units
Initially 35 babies were thought to have been exposed at the hospitals for the bacteria that causes TB, but officials lowered their estimate to 26 (Source: Health News: CBSNews.com)